{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:36:32Z","timestamp":1783467392164,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11060-025-05236-1","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:52:42Z","timestamp":1760554362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Meningioma grade and molecular markers of proliferation, hypoxia, and vascularity as predictors of outcome in a cohort with long-term patient follow-up"],"prefix":"10.1007","volume":"176","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6740-0883","authenticated-orcid":false,"given":"Saachi","family":"Jhandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3544-4116","authenticated-orcid":false,"given":"Eric","family":"Goold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2824-4221","authenticated-orcid":false,"given":"Randy L.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"5236_CR1","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","volume":"24","author":"QT Ostrom","year":"2022","unstructured":"Ostrom QT, Price M, Neff C et al (2022) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united States in 2015\u20132019. Neuro-Oncol 24:v1\u2013v95. https:\/\/doi.org\/10.1093\/neuonc\/noac202","journal-title":"Neuro-Oncol"},{"key":"5236_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/neuonc\/noz237","volume":"22","author":"F Nassiri","year":"2020","unstructured":"Nassiri F, Zadeh G (2020) How should we manage incidental meningiomas? Neuro-Oncol 22:173\u2013174. https:\/\/doi.org\/10.1093\/neuonc\/noz237","journal-title":"Neuro-Oncol"},{"key":"5236_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3171\/2014.7.JNS131644","volume":"122","author":"L Rogers","year":"2015","unstructured":"Rogers L, Barani I, Chamberlain M et al (2015) Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 122:4\u201323. https:\/\/doi.org\/10.3171\/2014.7.JNS131644","journal-title":"J Neurosurg"},{"key":"5236_CR4","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro-Oncol"},{"key":"5236_CR5","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0090-3019(86)90259-4","volume":"26","author":"J J\u00e4\u00e4skel\u00e4inen","year":"1986","unstructured":"J\u00e4\u00e4skel\u00e4inen J (1986) Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis. Surg Neurol 26:461\u2013469. https:\/\/doi.org\/10.1016\/0090-3019(86)90259-4","journal-title":"Surg Neurol"},{"key":"5236_CR6","first-page":"170","volume":"24","author":"SH Torp","year":"2005","unstructured":"Torp SH, Lindboe CF, Gr\u00f8nberg BH et al (2005) Prognostic significance of Ki-67\/MIB-1 proliferation index in meningiomas. Clin Neuropathol 24:170\u2013174","journal-title":"Clin Neuropathol"},{"key":"5236_CR7","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.prp.2010.09.002","volume":"206","author":"E Abry","year":"2010","unstructured":"Abry E, Thomassen I\u00d8, Salvesen \u00d8O, Torp SH (2010) The significance of Ki-67\/MIB-1 labeling index in human meningiomas: a literature study. Pathol Res Pract 206:810\u2013815. https:\/\/doi.org\/10.1016\/j.prp.2010.09.002","journal-title":"Pathol Res Pract"},{"key":"5236_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00701-003-0173-4","volume":"146","author":"F Roser","year":"2004","unstructured":"Roser F, Samii M, Ostertag H, Bellinzona M (2004) The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Acta Neurochir (Wien) 146:37\u201344 discussion 44. https:\/\/doi.org\/10.1007\/s00701-003-0173-4","journal-title":"Acta Neurochir (Wien)"},{"key":"5236_CR9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.5414\/NP300488","volume":"31","author":"M Preusser","year":"2012","unstructured":"Preusser M, Hassler M, Birner P et al (2012) Microvascularization and expression of VEGF and its receptors in recurring meningiomas: Pathobiological data in favor of anti-angiogenic therapy approaches. Clin Neuropathol 31:352\u2013360. https:\/\/doi.org\/10.5414\/NP300488","journal-title":"Clin Neuropathol"},{"key":"5236_CR10","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/2013.8.FOCUS13301","volume":"35","author":"J Hou","year":"2013","unstructured":"Hou J, Kshettry VR, Selman WR, Bambakidis NC (2013) Peritumoral brain edema in intracranial meningiomas: the emergence of vascular endothelial growth factor-directed therapy. Neurosurg Focus 35:E2. https:\/\/doi.org\/10.3171\/2013.8.FOCUS13301","journal-title":"Neurosurg Focus"},{"key":"5236_CR11","first-page":"344","volume":"38","author":"Y-S Ding","year":"2008","unstructured":"Ding Y-S, Wang H-D, Tang K et al (2008) Expression of vascular endothelial growth factor in human meningiomas and peritumoral brain areas. Ann Clin Lab Sci 38:344\u2013351","journal-title":"Ann Clin Lab Sci"},{"key":"5236_CR12","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1097\/00006123-200111000-00003","volume":"49","author":"T Tamiya","year":"2001","unstructured":"Tamiya T, Ono Y, Matsumoto K, Ohmoto T (2001) Peritumoral brain edema in intracranial meningiomas: effects of radiological and histological factors. Neurosurgery 49:1046\u20131051 discussion 1051\u20131052. https:\/\/doi.org\/10.1097\/00006123-200111000-00003","journal-title":"Neurosurgery"},{"key":"5236_CR13","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/apm.12052","volume":"121","author":"D Nassehi","year":"2013","unstructured":"Nassehi D, S\u00f8rensen LP, Dyrbye H et al (2013) Peritumoral brain edema in angiomatous supratentorial meningiomas: an investigation of the vascular endothelial growth factor A pathway. APMIS Acta Pathol Microbiol Immunol Scand 121:1025\u20131036. https:\/\/doi.org\/10.1111\/apm.12052","journal-title":"APMIS Acta Pathol Microbiol Immunol Scand"},{"key":"5236_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1136\/jnnp.20.1.22","volume":"20","author":"D Simpson","year":"1957","unstructured":"Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22\u201339. https:\/\/doi.org\/10.1136\/jnnp.20.1.22","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5236_CR15","doi-asserted-by":"publisher","unstructured":"Morshed RA, Nguyen MP, Choudhury A et al (2025) The impact of MRI-defined extent of resection across meningioma DNA methylation groups: Re-evaluating surgery in the era of meningioma molecular classification. Neurosurgery https:\/\/doi.org\/10.1227\/neu.0000000000003324","DOI":"10.1227\/neu.0000000000003324"},{"key":"5236_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1227\/NEU.0b013e3182567886","volume":"71","author":"R Jensen","year":"2012","unstructured":"Jensen R, Lee J (2012) Predicting outcomes of patients with intracranial meningiomas using molecular markers of hypoxia, vascularity, and proliferation. Neurosurgery 71:146\u2013156. https:\/\/doi.org\/10.1227\/NEU.0b013e3182567886","journal-title":"Neurosurgery"},{"key":"5236_CR17","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3171\/2016.10.JNS161825","volume":"128","author":"M Karsy","year":"2018","unstructured":"Karsy M, Burnett B, Di Ieva A et al (2018) Microvascularization of grade I meningiomas: effect on tumor volume, blood loss, and patient outcome. J Neurosurg 128:657\u2013666. https:\/\/doi.org\/10.3171\/2016.10.JNS161825","journal-title":"J Neurosurg"},{"key":"5236_CR18","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3171\/jns.2002.97.3.0658","volume":"97","author":"RL Jensen","year":"2002","unstructured":"Jensen RL, Soleau S, Bhayani MK, Christiansen D (2002) Expression of hypoxia inducible factor-1 alpha and correlation with preoperative embolization of meningiomas. J Neurosurg 97:658\u2013667. https:\/\/doi.org\/10.3171\/jns.2002.97.3.0658","journal-title":"J Neurosurg"},{"key":"5236_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (Berl) 114:97\u2013109. https:\/\/doi.org\/10.1007\/s00401-007-0243-4","journal-title":"Acta Neuropathol (Berl)"},{"key":"5236_CR20","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1200\/JCO.21.00784","volume":"39","author":"SLN Maas","year":"2021","unstructured":"Maas SLN, Stichel D, Hielscher T et al (2021) Integrated Molecular-Morphologic meningioma classification: A multicenter retrospective Analysis, retrospectively and prospectively validated. J Clin Oncol Off J Am Soc Clin Oncol 39:3839\u20133852. https:\/\/doi.org\/10.1200\/JCO.21.00784","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"5236_CR21","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/neuonc\/noab213","volume":"24","author":"J Driver","year":"2022","unstructured":"Driver J, Hoffman S, others Tavakol S (2022) A molecularly integrated grade for meningioma. Neuro Oncol 24:796\u2013808","journal-title":"Neuro Oncol"},{"key":"5236_CR22","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1093\/neuonc\/noac032","volume":"24","author":"AD Rebchuk","year":"2022","unstructured":"Rebchuk AD, Chaharyn BM, Alam A et al (2022) The impact of brain invasion criteria on the incidence and distribution of WHO grade 1, 2, and 3 meningiomas. Neuro-Oncol 24:1524\u20131532. https:\/\/doi.org\/10.1093\/neuonc\/noac032","journal-title":"Neuro-Oncol"},{"key":"5236_CR23","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1080\/02688697.2019.1639616","volume":"34","author":"LS Bulleid","year":"2020","unstructured":"Bulleid LS, James Z, Lammie A et al (2020) The effect of the revised WHO classification on the incidence of grade II meningioma. Br J Neurosurg 34:584\u2013586. https:\/\/doi.org\/10.1080\/02688697.2019.1639616","journal-title":"Br J Neurosurg"},{"key":"5236_CR24","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11060-020-03632-3","volume":"151","author":"P Soni","year":"2021","unstructured":"Soni P, Davison MA, Shao J et al (2021) Extent of resection and survival outcomes in world health organization grade II meningiomas. J Neurooncol 151:173\u2013179. https:\/\/doi.org\/10.1007\/s11060-020-03632-3","journal-title":"J Neurooncol"},{"key":"5236_CR25","doi-asserted-by":"publisher","first-page":"e331","DOI":"10.1016\/j.wneu.2024.04.082","volume":"187","author":"M Nadeem","year":"2024","unstructured":"Nadeem M, Goyal-Honavar A, Sravya P et al (2024) Prognostic factors and outcomes in world health organization grade 1 and grade 2 intracranial Meningiomas-5-Year institutional experience. World Neurosurg 187:e331\u2013e339. https:\/\/doi.org\/10.1016\/j.wneu.2024.04.082","journal-title":"World Neurosurg"},{"key":"5236_CR26","doi-asserted-by":"publisher","unstructured":"Sughrue ME, Sanai N, Shangari G et al (2010) Outcome and survival following primary and repeat surgery for world health. Organization Grade III meningiomas. https:\/\/doi.org\/10.3171\/2010.1.JNS091114","DOI":"10.3171\/2010.1.JNS091114"},{"key":"5236_CR27","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/jamaoncol.2016.1373","volume":"2","author":"TJ Brown","year":"2016","unstructured":"Brown TJ, Brennan MC, Li M et al (2016) Association of the extent of resection with survival in glioblastoma: A systematic review and meta-analysis. JAMA Oncol 2:1460\u20131469. https:\/\/doi.org\/10.1001\/jamaoncol.2016.1373","journal-title":"JAMA Oncol"},{"key":"5236_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3171\/2012.3.JNS111945","volume":"117","author":"S Oya","year":"2012","unstructured":"Oya S, Kawai K, Nakatomi H, Saito N (2012) Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO grade I meningiomas. J Neurosurg 117:121\u2013128. https:\/\/doi.org\/10.3171\/2012.3.JNS111945","journal-title":"J Neurosurg"},{"key":"5236_CR29","doi-asserted-by":"publisher","first-page":"e0303337","DOI":"10.1371\/journal.pone.0303337","volume":"19","author":"TM Aung","year":"2024","unstructured":"Aung TM, Ngamjarus C, Proungvitaya T et al (2024) Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis. PLoS ONE 19:e0303337. https:\/\/doi.org\/10.1371\/journal.pone.0303337","journal-title":"PLoS ONE"},{"key":"5236_CR30","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3171\/jns.1999.91.3.0375","volume":"91","author":"RE Mantle","year":"1999","unstructured":"Mantle RE, Lach B, Delgado MR et al (1999) Predicting the probability of meningioma recurrence based on the quantity of peritumoral brain edema on computerized tomography scanning. J Neurosurg 91:375\u2013383. https:\/\/doi.org\/10.3171\/jns.1999.91.3.0375","journal-title":"J Neurosurg"},{"key":"5236_CR31","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s10143-024-03116-2","volume":"47","author":"Y-Z Ying","year":"2024","unstructured":"Ying Y-Z, Li H-Y, Dong G-H et al (2024) Postoperative peritumoral edema is correlated with the prognosis in intracranial meningioma with preoperative peritumoral edema. Neurosurg Rev 47:872. https:\/\/doi.org\/10.1007\/s10143-024-03116-2","journal-title":"Neurosurg Rev"},{"key":"5236_CR32","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1007\/s12031-021-01801-1","volume":"71","author":"K Faropoulos","year":"2021","unstructured":"Faropoulos K, Polia A, Tsakona C et al (2021) Evaluation of AQP4\/TRPV4 channel Co-expression, microvessel Density, and its association with peritumoral brain edema in intracranial meningiomas. J Mol Neurosci MN 71:1786\u20131795. https:\/\/doi.org\/10.1007\/s12031-021-01801-1","journal-title":"J Mol Neurosci MN"},{"key":"5236_CR33","doi-asserted-by":"publisher","unstructured":"Reszec J, Hermanowicz A, Rutkowski R et al (2015) Expression of MMP-9 and VEGF in meningiomas and their correlation with peritumoral brain edema. BioMed Res Int 2015(646853). https:\/\/doi.org\/10.1155\/2015\/646853","DOI":"10.1155\/2015\/646853"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05236-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05236-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05236-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:34:33Z","timestamp":1767702873000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05236-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5236"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05236-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved as an extension of an earlier approved study by the Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}